(GLMD) Galmed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Galmed Pharmaceuticals | (GLMD) share price targets
Complete technical analysis of Galmed Pharmaceuticals (GLMD) by charts plus indicators, forecast predictions and share price targets for Galmed Pharmaceuticals (GLMD)
Galmed Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Galmed Pharmaceuticals is 19660
| Date | Daily Closing Price | Open | High | Low | Volume |
| 27 Mon Jan 2025 | 2.86 | 2.96 | 3.45 | 2.86 | 2.35 times |
| 24 Fri Jan 2025 | 2.93 | 2.86 | 3.04 | 2.86 | 2.467 times |
| 23 Thu Jan 2025 | 2.94 | 2.86 | 2.94 | 2.81 | 0.804 times |
| 22 Wed Jan 2025 | 2.85 | 2.90 | 2.94 | 2.85 | 0.468 times |
| 21 Tue Jan 2025 | 2.87 | 2.86 | 3.02 | 2.81 | 0.468 times |
| 17 Fri Jan 2025 | 2.90 | 2.93 | 3.00 | 2.80 | 0.956 times |
| 17 Fri Jan 2025 | 2.90 | 2.93 | 3.00 | 2.80 | 0.956 times |
| 16 Thu Jan 2025 | 2.93 | 2.79 | 2.98 | 2.79 | 0.997 times |
| 15 Wed Jan 2025 | 2.79 | 3.01 | 3.01 | 2.79 | 0.992 times |
| 14 Tue Jan 2025 | 2.82 | 2.94 | 2.98 | 2.82 | 0.473 times |
Stock of Galmed Pharmaceuticals (GLMD) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 2.8 as stoploss in an intra day buy trade for a target of 2.98. However, stock will show a bearish move below 2.8.
Share price targets for Galmed Pharmaceuticals (GLMD)
| Target Type | Value |
| Downside Target | 2.68 |
| Downside Target | 2.79 |
| Upside Target | 3.00 |
| Upside Target | 3.04 |
| Upside Target | 3.07 |
| Upside Target | 3.39 |
| Upside Target | 3.45 |
| Upside Target | 3.57 |
| Upside Target | 3.61 |
| Upside Target | 6.87 |
| Upside Target | 23.80 |
Intraday share price targets for Galmed Pharmaceuticals (GLMD)
| Target Type | Value |
| Downside Intraday Target | 2.66 |
| Downside Intraday Target | 2.47 |
| Upside Intraday Target | 3.25 |
| Upside Intraday Target | 3.65 |
| Upside Intraday Target | 3.06 |
Weekly technical analysis of Galmed Pharmaceuticals (GLMD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 27 Mon Jan 2025 | 2.86 | 2.96 | 3.45 | 2.86 | 0.559 times |
| 24 Fri Jan 2025 | 2.93 | 2.86 | 3.04 | 2.81 | 4.399 times |
| 17 Fri Jan 2025 | 2.90 | 2.93 | 3.00 | 2.80 | 0.198 times |
| 17 Fri Jan 2025 | 2.90 | 2.93 | 3.01 | 2.79 | 2.222 times |
| 10 Fri Jan 2025 | 2.90 | 2.91 | 3.07 | 2.84 | 0.242 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galmed Pharmaceuticals (GLMD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 27 Mon Jan 2025 | 2.86 | 3.20 | 3.61 | 2.79 | 0.793 times |
| 31 Tue Dec 2024 | 3.19 | 2.80 | 3.39 | 2.73 | 0.689 times |
| 26 Tue Nov 2024 | 2.87 | 3.34 | 3.57 | 2.68 | 0.261 times |
| 31 Thu Oct 2024 | 3.34 | 6.85 | 6.87 | 3.04 | 0.024 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Galmed Pharmaceuticals (GLMD)
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Galmed Pharmaceuticals in short term but the buy signal is initial and weak.
Galmed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Galmed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Galmed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.89 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Galmed Pharmaceuticals in short term but the buy signal is initial and weak.
Galmed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a buy signal for Galmed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Galmed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.89 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.